The hepatitis C genotype 1 paradox: cost per treatment is increasing, but cost per cure is decreasing [0.03%]
基因型为1的丙型肝炎悖论：尽管每个治疗的成本在上升，但每治愈一个病人成本却下降了
Stephen D Shafran
Stephen D Shafran
Significant attention has been focused on the perceived increase in the cost of antiviral treatment for hepatitis C genotype 1 infection since the approval of the first direct-acting antiviral agents in 2011. Using Canadian list prices, the...
Matthew B Lanktree,Bruce B Lanktree,Guillaume Paré et al.
Matthew B Lanktree et al.
Background: Hereditary hemochromatosis leads to an increased lifetime risk for end-organ damage due to excess iron deposition. Guidelines recommend that genetic testing be performed in patients with clinical suspicion of ...
A study investigating the association of dermatological and infusion reactions to infliximab and infliximab trough levels [0.03%]
有关英夫利昔α疗法患者的皮肤反应和输液反应与血清药物浓度关联性的研究
Vivian Huang,Neil Dhami,Darryl Fedorak et al.
Vivian Huang et al.
Background: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these advers...
Harith Baharith,Khurram Khan
Harith Baharith
Genetic testing for hemochromatosis: diagnostic or confirmatory test for iron overload? [0.03%]
遗传学检测与血色素沉着症：铁过载的诊断或确认试验？
Paul C Adams
Paul C Adams
An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver [0.03%]
2015年加拿大肝病研究协会慢性丙型肝炎管理专家共识意见更新
Robert P Myers,Hemant Shah,Kelly W Burak et al.
Robert P Myers et al.
Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting nearly 1% of the population. Since the last Canadian consensus conference on the management of chronic hepatitis C, major advances have occurred that...
Sunny S Lee,Robert Enns
Sunny S Lee
Manuela G Neuman,Lawrence B Cohen,Radu M Nanau
Manuela G Neuman
Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition characterized by insulin resistance, type 2 diabetes and fat accumulation in the liver that may cause hepatic inflammation and progressive ...
Catherine Dubé
Catherine Dubé